Navigation

Clinical audit

NICE produces clinical audit tools for local clinical audit to improve care, containing clinical audit standards based on NICE guidance.

The most recent documents are Excel based and also contain:

  • a data collection sheet
  • a clinical audit report that provides basic information about the audit and automatically displays the audit results
  • an action plan template
  • an appendix containing a printable data collection form.

Previous versions of the Clinical audit tools produced by NICE to accompany guidance were called Audit support or Audit criteria.

Access all the clinical audit documents from the list below. The most recent clinical audit tools can be found at the bottom of the list.

For quick access to some recent examples of the clinical audit tools we produce, please follow the links below:

Clinical audit tools for CG156 Fertility

Clinical audit tools for CG157 Hyperphosphataemia in chronic kidney disease

Clinical audit tool for CG158 Conduct disorders in children and young people

Tell us what you think

We want to hear what you think of clinical audit and your experiences of using them.

Details of some of the work we have done to improve our audit tools can be found in the NICE clinical audit survey report 2011.

External Reference Group

If you are a clinical audit specialist or healthcare professional who would be prepared to help us review the clinical audit tools, please apply to join our 'Audit Panel'.

Results 41-60 of 371

Ref Title Setting
PH2 Four commonly used methods to increase physical activity: audit criteria
PH1 Brief interventions and referral for smoking cessation: audit criteria
PH3 Prevention of sexually transmitted infections and under 18 conceptions: audit criteria
PH5 Workplace interventions to promote smoking cessation: audit criteria (for PCTs and their providers)
TA34 Breast cancer - trastuzumab: advanced breast cancer technology appraisals clinical audit tool General
TA61 Colorectal cancer - capecitabine and tegafur uracil: chemotherapy for advanced and metastatic colorectal cancer - clinical audit tool General
TA68 Macular degeneration (age-related) - photodynamic therapy: clinical audit tool General
TA101 Prostate cancer (hormone-refractory) - docetaxel: multiple guidance audit tool General
TA107 Breast cancer (early) - trastuzumab: audit criteria
TA107 Breast cancer (early) - trastuzumab: multiple guidance audit tool General
TA109 Breast cancer (early) - docetaxel: audit criteria
TA109 Breast cancer (early) - docetaxel: multiple guidance audit tool General
TA108 Breast cancer (early) - paclitaxel: multiple guidance audit tool General
TA112 Breast cancer (early) - hormonal treatments: audit criteria
TA112 Breast cancer (early) - hormonal treatments: multiple guidance audit tool General
TA115 Drug misuse - naltrexone: audit criteria
TA114 Drug misuse - methadone and buprenorphine: audit criteria
TA117 Hyperparathyroidism - cinacalcet: audit criteria General
TA116 Breast cancer - gemcitabine: advanced breast cancer technology appraisals clinical audit tool General
TA118 Colorectal cancer (metastatic) - bevacizumab and cetuximab: biological agents for metastatic colorectal cancer - clinical audit tool General

This page was last updated: 05 June 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.